![[Executive Summary: CDDF-EORTC Joint Workshop on Innovation and Access in Rare Cancers (23-24 September 2024, Amsterdam, NL)]](https://cddf.org/wp-content/uploads/2024/10/CDDF-EORTC-Workshop-on-Rare-Cancer_Sep2024_Executive-Summary_Image-1-1080x675.jpg)
CDDF Job Opening: Community & Communication Coordinator
The Cancer Drug Development Forum (CDDF) is seeking a talented Community & Communication Coordinator to be part of our dynamic team in Brussels. Join the CDDF team to contribute to a meaningful mission that accelerates the delivery of effective cancer treatments....
Key Takeaways from the CDDF-EORTC Workshop on Innovation and Access in Rare Cancers (23-24 Sep 2024, Amsterdam)
The first day of the CDDF workshop on Rare Cancers brought together a diverse group of stakeholders into open, constructive discussions in order to improve access to innovative therapies for patients with rare cancers. Here are the key takeaways from Day 1’s program:...
🔔 📢 Key Takeaways from the CDDF-ESMO Joint Session, “Regulatory Challenges in Clinical Cancer Drug Development” (16 Sep 2024)
The CDDF & ESMO educational session on “Regulatory Challenges in Clinical Cancer Drug Development” took place on 16 September 2024 at ESMO 2024. In this session, Aaron E. Sosa Mejia (Danish Medicines Agency) and Audrey Wolf (EFPIA) gave presentations...![[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]](https://cddf.org/wp-content/uploads/2024/09/Copy-of-Copy-of-Copy-of-Dark-Purple-and-Blue-Texture-Blur-Circle-Business-Marketing-Presentation-1080x675.jpg)
[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]
We are delighted to announce that the Cancer Drug Development Forum (CDDF) has launched its initiative on diversity in oncology clinical trials. CDDF cordially invites pharmaceutical companies to participate in this collaborative effort to support the planning and...